view1st Group Ltd

1ST Group crosses major milestone in online appointment booking

Over 5 million appointments booked on the portal since 2012.

Recently signed an agreement with Mylan N.V.

1st Group (ASX:1ST) has crossed a major milestone by booking over 5 million appointments on its cloud-based online health portal since 2012.

The company’s secure portal enables patients to schedule appointments, receive automated appointment reminders and provide feedback to their practitioners.

The number of new patients using 1st Group’s appointment booking platform on a monthly basis has surged 700% since 2015.

Presently, almost 60% of all appointments on the platform are made during business hours, up from 48% just two years ago.

This validates 1st Group’s value proposition to practices of making reception desks more efficient, reducing practice administration costs and driving greater convenience for patients.

1ST Group’s first half of FY17 laid the foundations for a potentially stronger revenue and sales growth in the second half, securing major deals with Alphapharm and ProVision in Q2 2017.

Alphapharm, a wholly owned subsidiary of Mylan N.V., is one of the world's leading global pharmaceutical companies.

Customers of Alphapharm’s 410 stores will be able to use 1stAvailable portal and book online services such as flu shots, diabetes and other healthcare services.

There are significant growth opportunities in 2017, following the shift in consumer trends and increasing government initiatives in digitising healthcare such as the launch of the Australian Digital Health Agency in 2016.

1ST Group’s shares were last trading 4.26% higher intra-day on Monday, at $0.049.

Quick facts: 1st Group Ltd

Price: 0.031 AUD

Market: ASX
Market Cap: $13.16 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


archTIS makes transformative move in acquiring Nucleus Cyber

archTIS (ASX: AR9) CEO Daniel Lai joins Steve Darling from Proactive to share details of a transformative acquisition with the company entering a binding term sheet to acquire global information protection business Nucleus Cyber. Lai discusses why this is a key move for the company...

1 hour, 51 minutes ago

2 min read